| Original language | English |
|---|---|
| Pages (from-to) | B33 |
| Number of pages | 1 |
| Journal | Molecular Cancer Therapeutics |
| Volume | 14 |
| Issue number | 7, Suppl. |
| DOIs | |
| Publication status | Published - Jul 2015 |
| Event | American Association for Cancer Research Special Conference: Targeting he PI3K-mTOR Network in Cancer - Philadelphia, United States Duration: 14 Sep 2014 → 17 Sep 2014 |
Cite this
Tashkandi, G., Goltsov, A., Mullen, P., Bown, J., Harrison, D., & Langdon, S. (2015). Understanding resistance mechanisms to PI3K/mTOR inhibitors in ovarian cancer model systems. Molecular Cancer Therapeutics, 14(7, Suppl.), B33. https://doi.org/10.1158/1538-8514.PI3K14-B33
@article{d13feb66bd484dd0b08b3030d8fd1032,
title = "Understanding resistance mechanisms to PI3K/mTOR inhibitors in ovarian cancer model systems",
author = "Ghassan Tashkandi and Alexey Goltsov and Peter Mullen and James Bown and David Harrison and Simon Langdon",
year = "2015",
month = "7",
doi = "10.1158/1538-8514.PI3K14-B33",
language = "English",
volume = "14",
pages = "B33",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research Inc.",
number = "7, Suppl.",
}
Tashkandi, G, Goltsov, A, Mullen, P, Bown, J, Harrison, D & Langdon, S 2015, 'Understanding resistance mechanisms to PI3K/mTOR inhibitors in ovarian cancer model systems', Molecular Cancer Therapeutics, vol. 14, no. 7, Suppl., pp. B33. https://doi.org/10.1158/1538-8514.PI3K14-B33
Understanding resistance mechanisms to PI3K/mTOR inhibitors in ovarian cancer model systems. / Tashkandi, Ghassan; Goltsov, Alexey; Mullen, Peter; Bown, James; Harrison, David; Langdon, Simon.
In: Molecular Cancer Therapeutics, Vol. 14, No. 7, Suppl., 07.2015, p. B33.Research output: Contribution to journal › Meeting Abstract
TY - JOUR
T1 - Understanding resistance mechanisms to PI3K/mTOR inhibitors in ovarian cancer model systems
AU - Tashkandi, Ghassan
AU - Goltsov, Alexey
AU - Mullen, Peter
AU - Bown, James
AU - Harrison, David
AU - Langdon, Simon
PY - 2015/7
Y1 - 2015/7
U2 - 10.1158/1538-8514.PI3K14-B33
DO - 10.1158/1538-8514.PI3K14-B33
M3 - Meeting Abstract
VL - 14
SP - B33
JO - Molecular Cancer Therapeutics
JF - Molecular Cancer Therapeutics
SN - 1535-7163
IS - 7, Suppl.
ER -
Tashkandi G, Goltsov A, Mullen P, Bown J, Harrison D, Langdon S. Understanding resistance mechanisms to PI3K/mTOR inhibitors in ovarian cancer model systems. Molecular Cancer Therapeutics. 2015 Jul;14(7, Suppl.):B33. https://doi.org/10.1158/1538-8514.PI3K14-B33